Japan Struggles to Fit Into Agreement on SDI

TOKYO—Some four months after Japan agreed to join the Strategic Defense Initiative championed by the Reagan administration, the scope and nature of its participation remain unclear. “We have only just finished studying what kind of cooperation and what kind of regulations are involved,” said Koji Inoue, assistant section chief of the Aircraft and Ordinance division of Japan’s Ministry of International Trade and Industry (MITI). “So far, no specific corporations.

Written byJohn Boyd
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

TOKYO—Some four months after Japan agreed to join the Strategic Defense Initiative championed by the Reagan administration, the scope and nature of its participation remain unclear.

“We have only just finished studying what kind of cooperation and what kind of regulations are involved,” said Koji Inoue, assistant section chief of the Aircraft and Ordinance division of Japan’s Ministry of International Trade and Industry (MITI). “So far, no specific corporations. have been named because we are still defining the various ways companies can apply for participation.”

The U.S. Defense Department has listed 16 fields in which Japanese expertise might advance the SDI program. These include optical data storage, gallium arsenide semiconductors, microwave and millimeter-wave technology, composite materials and superconduc tors. Most of Japan’s major electronics companies have expressed interest in the project

Yet the two countries have differing views of SDI. According to Koji Fushimi, a member of the national Diet ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies